Juan Du
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · RenJi Hospital · Shanghai Changzheng Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
18
all conditions, ClinicalTrials.gov
NIH grants tied to them
0
6 more share only the name and are not shown
Trial papers
389
PubMed author-name match
Trials
Studies that name Juan Du as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:30 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07831993 · Sintilimab Plus NALIRIFOX or Gemcitabine-Cisplatin as First-Line Treatment for Metastatic Biliary Tract CancerThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · recruiting · Biliary Tract Cancer · principal investigator
- Ph2NCT07797816 · Liposomal Irinotecan Plus 5-FU/LV and Sintilimab With Sequential SBRT for Locally Advanced Biliary Tract CancerThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · recruiting · Biliary Tract Cancer · principal investigator
- N/ANCT07028970 · Long-term Follow-up Registry Study of Equecabtagene Autoleucel InjectionNanjing IASO Biotechnology Co., Ltd. · recruiting · Multiple Myeloma · principal investigator
- Early Ph1NCT06718270 · a Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Plasma Cell LeukemiaShanghai Changzheng Hospital · recruiting · Relapsed/Refractory Multiple Myeloma, Relapsed/Refractory Plasma Cell Leukemia · principal investigator
- Ph2NCT06662006 · Nal-IRI/5-FU/LV Chemotherapy Combined With PD-L1 Inhibitor and Multi-target Anti-angiogenic Small Molecule±SBRT as Second-line Therapy in Metastatic Pancreatic Cancer PatientsThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · recruiting · Advanced Metastatic Pancreatic Cancer · study chair
- N/ANCT06494514 · NALIRIFOX Combined With PD-1 Sequential Radiotherapy Versus AG Combined With PD-1 Sequential Radiotherapy as First-line Treatment of Locally Advanced Pancreatic CancerDu Juan · recruiting · Locally Advanced Pancreatic Cancer · principal investigator
- Ph2NCT06389760 · Nimotuzumab Combined With mFOLFIRINOX/GX as Postoperative Adjuvant Therapy in Pancreatic CancerThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · unknown · Pancreatic Cancer · study chair
- Ph2NCT06051851 · Penpulimab Combined With Anlotinib and Nab-paclitaxel Plus Gemcitabine as First-line Treatment for Advanced Metastatic Pancreatic CancerThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · unknown · Pancreatic Adenocarcinoma Metastatic · principal investigator
- Early Ph1NCT06045091 · To Evaluate the Safety and Efficacy of Human BCMA Targeted CAR-NK Cells Injection for Subjects With R/R MM or PCLHrain Biotechnology Co., Ltd. · recruiting · Multiple Myeloma, Plasma Cell Leukemia · principal investigator
- Ph2NCT05979948 · A Phase 2 Clinical Trial to Evaluate Zanubrutinib Combined With BR (Bendamustine/Rituximab) Regimen in Subjects With Newly-diagnosed Waldenström's MacroglobulinemiaShanghai Changzheng Hospital · unknown · Waldenström's Macroglobulinemia · principal investigator
- Early Ph1NCT05840107 · Study of FasT CAR-T GC012F Injection NDMM PatientsShanghai Changzheng Hospital · unknown · Multiple Myeloma · principal investigator
- Early Ph1NCT05838131 · Study of CT071 Injection in RRMM or PPCLShanghai Changzheng Hospital · active not recruiting · Multiple Myeloma, Primary Plasma Cell Leukemia · principal investigator
- Ph2NCT05594797 · Human BCMA Targeted T Cells Injection（BCMA CAR-T）for Subjects With R/R MMHrain Biotechnology Co., Ltd. · recruiting · Multiple Myeloma · principal investigator
- Ph1NCT05412329 · Study of Dual Targeted CD19/BCMA FASTCART GC012F in Relapsed/ Refractory Multiple MyelomaShanghai Changzheng Hospital · unknown · Multiple Myeloma · principal investigator
- Early Ph1NCT05302648 · To Evaluate the Safety and Efficacy of Human Derived Anti-BCMA CAR-T Injection for Subjects with R/R MMHrain Biotechnology Co., Ltd. · active not recruiting · Multiple Myeloma · principal investigator
- Ph2NCT04941937 · Selinexor in Combination With Immunomodulator （Thalidomide/Pomalidomide/Lenalidomide）in RRMMJuan Du · unknown · Multiple Myeloma · principal investigator
- Ph1/Ph2NCT04935580 · Study of FasT CAR-T GC012F Injection in High Risk TE NDMM PatientsShanghai Changzheng Hospital · unknown · Multiple Myeloma · principal investigator
- Ph1NCT03973073 · Effects of Combination Therapy With Camouflage in the Repigmentation of VitiligoPeking University People's Hospital · completed · Vitiligo · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:30 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 6 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 04:30 UTC. The ranking covers the 200 most relevant of 389 PubMed records, and a shared surname and initials can bring in a namesake. All 389 on PubMed
- Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients.N Engl J Med · 20221,504 citationsRCR 115.4
- Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults.N Engl J Med · 2023452 citationsRCR 44.9
- 349 citationsRCR 24.8
- Exploratory trial of a biepitopic CAR T-targeting B cell maturation antigen in relapsed/refractory multiple myeloma.Proc Natl Acad Sci U S A · 2019332 citationsRCR 11.4
- Perioperative Rosuvastatin in Cardiac Surgery.N Engl J Med · 2016246 citationsRCR 9.7
- Tiotropium in Early-Stage Chronic Obstructive Pulmonary Disease.N Engl J Med · 2017229 citationsRCR 10.0
- 193 citationsRCR 16.8
- 172 citationsRCR 14.7
- 165 citationsRCR 10.9
- Prognostic impact of minimal residual disease in CBFB-MYH11-positive acute myeloid leukemia.J Clin Oncol · 2010120 citationsRCR 2.8